Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing.
Karyn
K
Hede
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy; D002170:Canada; D018275:Carcinoma, Lobular / Q000737:chemistry; D004502:Education, Medical, Continuing; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D007755:Laboratories, Hospital / Q000592:standards*; D009523:Newfoundland and Labrador; D010336:Pathology / Q000592:standards*; D011785:Quality Assurance, Health Care; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis*; D012941:Social Responsibility; D014481:United States; D000078329:Workforce
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen